JP

Norio Masumoto

This inventor holds 0 USPTO granted patents, plus 6 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norio Masumoto. Retrieved from https://idiyas.com/inventor/norio-masumoto-9fuvht9p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Norio Masumoto: Innovator in Human Growth Hormone Research

Introduction

Norio Masumoto is a notable inventor from Japan, recognized for his contributions to the field of medical research. His work primarily focuses on the use of human growth hormone in innovative therapeutic applications.

Latest Patents

Masumoto holds a significant patent titled "Use of Human Growth Hormone in Mouse Carrying Human Hepatocytes." This patent describes a method where human adult hepatocytes are transplanted into a mouse suffering from immune-deficient liver injury. Following the transplantation, human growth hormone is administered to the mouse, resulting in an elevated substitution ratio of human adult hepatocytes. Additionally, the patent outlines the administration of human growth hormone to a mouse with human young hepatocytes to ameliorate fatty liver conditions.

Career Highlights

Throughout his career, Norio Masumoto has worked with prominent organizations such as Riken Corporation and Phoenixbio Co., Ltd. His research has significantly advanced the understanding of liver diseases and potential treatments.

Collaborations

Masumoto has collaborated with esteemed colleagues, including Chise Mukaidani and Katsutoshi Yoshizato, contributing to various research projects and innovations in the field.

Conclusion

Norio Masumoto's work in the application of human growth hormone in medical research showcases his innovative spirit and dedication to advancing healthcare solutions. His contributions continue to influence the field and inspire future research endeavors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…